This study evaluates the role of the bacterial environments and metabolites in the early detection and prediction of ovarian cancer development.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT06962059.
Locations matching your search criteria
United States
Pennsylvania
Philadelphia
University of Pennsylvania/Abramson Cancer CenterStatus: Active
Contact: Susan M. Domchek
Phone: 215-615-3360
PRIMARY OBJECTIVE:
I. To investigate the involvement of the microbiome and associated metabolites in ovarian cancer and generate a predictive model for ovarian cancer risk and progression.
OUTLINE: This is an observational study.
Participants undergo self administered vaginal swab and stool sample and complete surveys on study.
Trial PhaseNo phase specified
Trial Typebasic science
Lead OrganizationUniversity of Pennsylvania/Abramson Cancer Center
Principal InvestigatorSusan M. Domchek